Zimmer Biomet Holdings EMEA — Revenue decreased by 2.3% to $489.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.9%, from $441.70M to $489.90M. Over 4 years (FY 2021 to FY 2025), EMEA — Revenue shows an upward trend with a 5.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher revenue indicates strong market penetration and successful product adoption in the EMEA orthopedic market.
Total revenue generated from the sale of orthopedic products and services within the EMEA region, net of sales taxes. Th...
Core metric for evaluating regional performance against global medical device competitors.
zbh_segment_emea_revenue_from_contract_with_customer_excluding_assessed_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $376.80M | $354.50M | $411.50M | $379.90M | $379.90M | $319.30M | $377.40M | $425.60M | $402.90M | $337.90M | $426.00M | $444.80M | $432.40M | $376.20M | $437.70M | $441.70M | $467.50M | $417.00M | $501.30M | $489.90M |
| QoQ Change | — | -5.9% | +16.1% | -7.7% | +0.0% | -16.0% | +18.2% | +12.8% | -5.3% | -16.1% | +26.1% | +4.4% | -2.8% | -13.0% | +16.3% | +0.9% | +5.8% | -10.8% | +20.2% | -2.3% |
| YoY Change | — | — | — | — | +0.8% | -9.9% | -8.3% | +12.0% | +6.1% | +5.8% | +12.9% | +4.5% | +7.3% | +11.3% | +2.7% | -0.7% | +8.1% | +10.8% | +14.5% | +10.9% |